Literature DB >> 8443732

Age and gender as factors in cancer therapy.

P A Ganz1.   

Abstract

Cancer is already a disease of the elderly, and this will be increasingly the case as US population demographics continue to shift. The existing patterns of care for older cancer patients must be changed to improve the current cancer survival statistics. High technology innovations are not a prerequisite to improve our current results. The current best standards of care for cancer screening and treatment must be applied to the older woman. Although older patients may seem more comfortable (at least to a physician) with a paternalistic style of practice than younger patients, it is not in their best interest to exclude them from participation in their care. The health professional's assessment of the older patient's quality of life may miss the mark, denying them curative treatments as a result. Health care providers must learn to take the time to include older patients in their medical care and to educate them about the benefits of screening and cancer treatment.

Entities:  

Mesh:

Year:  1993        PMID: 8443732

Source DB:  PubMed          Journal:  Clin Geriatr Med        ISSN: 0749-0690            Impact factor:   3.076


  5 in total

Review 1.  Defining treatment aims and end-points in older patients with cancer.

Authors:  C E Desch; T J Smith
Journal:  Drugs Aging       Date:  1995-05       Impact factor: 3.923

Review 2.  A two way view of gender bias in medicine.

Authors:  M T Ruiz; L M Verbrugge
Journal:  J Epidemiol Community Health       Date:  1997-04       Impact factor: 3.710

Review 3.  Cancer chemotherapy in older adults. A tolerability perspective.

Authors:  G G Kimmick; R Fleming; H B Muss; L Balducci
Journal:  Drugs Aging       Date:  1997-01       Impact factor: 3.923

4.  A pilot study of patient quality of life during radiation therapy treatment.

Authors:  D J Johnson; L Casey; B Noriega
Journal:  Qual Life Res       Date:  1994-08       Impact factor: 4.147

5.  Position paper by the UKCCCR elderly cancer patients in clinical trials working group.

Authors: 
Journal:  Br J Cancer       Date:  2000-01       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.